These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2781509)

  • 1. Antithrombin Chicago, amino acid substitution of arginine 393 to histidine.
    Erdjument H; Lane DA; Panico M; Di Marzo V; Morris HR; Bauer K; Rosenberg RD
    Thromb Res; 1989 Jun; 54(6):613-9. PubMed ID: 2781509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel amino acid substitution in the reactive site of a congenital variant antithrombin. Antithrombin pescara, ARG393 to pro, caused by a CGT to CCT mutation.
    Lane DA; Erdjument H; Thompson E; Panico M; Di Marzo V; Morris HR; Leone G; De Stefano V; Thein SL
    J Biol Chem; 1989 Jun; 264(17):10200-4. PubMed ID: 2722864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow.
    Erdjument H; Lane DA; Panico M; Di Marzo V; Morris HR
    J Biol Chem; 1988 Apr; 263(12):5589-93. PubMed ID: 3162733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys.
    Erdjument H; Lane DA; Ireland H; Di Marzo V; Panico M; Morris HR; Tripodi A; Mannucci PM
    Thromb Haemost; 1988 Dec; 60(3):471-5. PubMed ID: 3238650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis.
    Lane DA; Erdjument H; Flynn A; Di Marzo V; Panico M; Morris HR; Greaves M; Dolan G; Preston FE
    Br J Haematol; 1989 Jan; 71(1):91-6. PubMed ID: 2917133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.
    Lindo VS; Kakkar VV; Learmonth M; Melissari E; Zappacosta F; Panico M; Morris HR
    Br J Haematol; 1995 Mar; 89(3):589-601. PubMed ID: 7734359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate.
    Caso R; Lane DA; Thompson EA; Olds RJ; Thein SL; Panico M; Blench I; Morris HR; Freyssinet JM; Aiach M
    Br J Haematol; 1991 Jan; 77(1):87-92. PubMed ID: 1998601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of antithrombin Barcelona-2: 47 arginine to cysteine.
    Owen MC; Shaw GJ; Grau E; Fontcuberta J; Carrell RW; Boswell DR
    Thromb Res; 1989 Aug; 55(4):451-7. PubMed ID: 2814937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.
    Borg JY; Owen MC; Soria C; Soria J; Caen J; Carrell RW
    J Clin Invest; 1988 Apr; 81(4):1292-6. PubMed ID: 3350974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin binding defect in a new antithrombin III variant: Rouen, 47 Arg to His.
    Owen MC; Borg JY; Soria C; Soria J; Caen J; Carrell RW
    Blood; 1987 May; 69(5):1275-9. PubMed ID: 3567355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleiotropic effects of antithrombin strand 1C substitution mutations.
    Lane DA; Olds RJ; Conard J; Boisclair M; Bock SC; Hultin M; Abildgaard U; Ireland H; Thompson E; Sas G
    J Clin Invest; 1992 Dec; 90(6):2422-33. PubMed ID: 1469094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin Rouen-IV 24 Arg----Cys. The amino-terminal contribution to heparin binding.
    Borg JY; Brennan SO; Carrell RW; George P; Perry DJ; Shaw J
    FEBS Lett; 1990 Jun; 266(1-2):163-6. PubMed ID: 2365065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin "Northwick Park".
    Erdjument H; Lane DA; Ireland H; Panico M; Di Marzo V; Blench I; Morris HR
    J Biol Chem; 1987 Oct; 262(28):13381-4. PubMed ID: 3654616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
    Brennan SO; Borg JY; Shaw GJ; Caen J; George PM
    Pathology; 1991 Jan; 23(1):1-4. PubMed ID: 2062560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid identification of specific mutations in the sequence of an enzyme variant produced by protein engineering using high-performance liquid chromatographic/fast atom bombardment mass spectrometric techniques.
    van Dongen WD; van Bommel JH; van Wassenaar PD; Heerma W; Haverkamp J
    Biol Mass Spectrom; 1994 Nov; 23(11):675-81. PubMed ID: 7811756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region.
    Dawes J; James K; Lane DA
    Biochemistry; 1994 Apr; 33(14):4375-83. PubMed ID: 7512382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.